PhD Biomedical Sci. My goal is to continue in the pharmaceutical and diagnostic industries. My experiences range from discovery research [oncology & endocrinology], medical and clinical affairs activities, design of PD strategy for clinical protocols, companion diagnostics, central/reference laboratory contracts, and promotion of my company's drug pipelines or test platforms with KOLs. I have a wholesome view of biology and pathobiology from the molecular level to the whole organism. Harnessing this education allows me to focus on the areas that have the greatest medical impact. I know how to manage the risk by establishing Go/NoGo points in quick ‘POC' studies, and if there is failure, then new directions/ideas can be tested. I have learned to avoid blind application of complex molecular profiles, which can siphon valuable resources and delay timelines and clinical trials. Success requires judicious application of resources and rigorous acceptance criteria selecting only those candidates with the highest probability of success and fall within the business portfolio. I have a firm understanding of the potential role that biomarkers will play in healthcare and I know the business implications and risks of identifying and using diagnostic tests to tailor drugs or regimens to optimally treat a patient. Know the test limitations, use caution against over-reliance on one ‘surrogate’, and determine if the test is ‘value added’ to current standard of care. In summary, I have the skills to set up focused programs to provide knowledge to support rational, scientific based development for targeted therapeutics, biomarkers, and diagnostics.Specialties: Pharmaceutical and Diagnostics. Translational Medicine Discovery to Clinic, Biomarkers, Molecular Pathology, Target Validation, Medical and Clinical Affairs
